Hostname: page-component-74656f9884-c52kr Total loading time: 0 Render date: 2026-11-08T10:48:30.299Z Has data issue: false hasContentIssue false

Effect of Wolbachia on insecticide susceptibility in lines of Aedes aegypti

Published online by Cambridge University Press:  13 November 2012

N.M. Endersby*
Affiliation:
Department of Genetics, Bio21 Institute, The University of Melbourne, Victoria 3010, Australia
A.A. Hoffmann
Affiliation:
Department of Genetics, Bio21 Institute, The University of Melbourne, Victoria 3010, Australia
*
* Author for correspondence Fax: +61 3 8344 2279 E-mail: nancye@unimelb.edu.au
Rights & Permissions [Opens in a new window]

Abstract

Two stable infections of Wolbachia pipientis, wMelPop and wMel, now established in Aedes aegypti, are being used in a biocontrol program to suppress the transmission of dengue. Any effects of Wolbachia infection on insecticide resistance of mosquitoes may undermine the success of this program. Bioassays of Ae. aegypti were conducted to test for differences in response to insecticides between Wolbachia infected (wMelPop, wMel) and uninfected lines. Insecticides screened were bifenthrin, the pyrethroid commonly used for adult knockdown, as well as larvicides: Bacillus thuringiensis var. israelensis, the organophosphate, temephos and the insect growth regulator, s-methoprene. While differences in response between lines were detected for some insecticides, no obvious or consistent effects related to presence of Wolbachia infection were observed. Spreading Wolbachia infections are, therefore, unlikely to affect the efficacy of traditional chemical control of mosquito outbreaks.

Information

Type
Research Paper
Copyright
Copyright © Cambridge University Press 2012
Figure 0

Table 1. Lines of Aedes aegypti (Wolbachia-infected and uninfected) used in insecticide bioassays.

Figure 1

Table 2. Insecticides used to bioassay lines of Aedes aegypti.

Figure 2

Table 3. Knockdown concentrations of bifenthrin (ppm) for Aedes aegypti at 1 and 24 h after exposure from lines infected with wMelPop or wMel compared with uninfected (u) lines – confidence intervals and heterogeneity factor were generated by Probit analysis.

Figure 3

Fig. 1. Susceptibility of lines of Aedes aegypti to Bacillus thuringiensis subsp. israelensis (VectoBac® WG) (48 h, 26 °C) −LC10 to LC50 with 95% confidence intervals (Comparison 1). Confidence intervals were generated by Probit analysis using PoloPlus.

Figure 4

Table 4. Bioassays of Aedes aegypti with VectoBac® WG Aedes aegypti 48 h 26 °C (BC, backcrossed line: line backcrossed to field line) (Comparison 1) – confidence intervals and heterogeneity factor were generated by Probit analysis.

Figure 5

Fig. 2. LC30 and LC50 (with 95% confidence intervals) of VectoBac® WG for lines of Aedes aegypti infected with wMelPop (C67 is the uninfected line) at 24 h and 48 h. Confidence intervals were generated by Probit analysis using PoloPlus.

Figure 6

Fig. 3. LC30 and LC50 (with 95% confidence intervals) of VectoBac® WG for lines of Aedes aegypti infected with wMel (C89 is the uninfected line) at 24 h and 48 h. Confidence intervals were generated by Probit analysis using PoloPlus.

Figure 7

Fig. 4. Percentage mortality and delayed development of Aedes aegypti larvae exposed to s-methoprene for 13 days (Comparison 1).

Figure 8

Fig. 5. Percentage mortality and delayed development of Aedes aegypti larvae exposed to s-methoprene for 13 days (Comparison 2).

Figure 9

Table 5. Effect of temephos (0 & 0.001 ppm, 24 h, 26 °C) on Aedes aegypti (Wolbachia-infected vs uninfected larvae).